All lobbying filings

KILPATRICK TOWNSEND AND STOCKTON

KILPATRICK TOWNSEND AND STOCKTON filed a Q3 report for PHAROS CAPITAL GROUP on October 22, 2026, reporting $70,000 in lobbying income.

Lobbying for PHAROS CAPITAL GROUP · Investment group that focuses investments on growing healthcare companies.

All filings by KILPATRICK TOWNSEND AND STOCKTON · Everything PHAROS CAPITAL GROUP has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 22, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

Tennessee

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Rural Health Transformation Program - implementation and health service eligibility - General healthcare issues. IHS Special Diabetes Program.

Medicare/Medicaid

Rural Health Transformation Program - implementation and health service eligibility - General healthcare issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.